Treace Medical Concepts (TMCI) News Today $6.96 +0.06 (+0.87%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $8.40 at Truist FinancialDecember 20 at 3:23 AM | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Hold" from BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received a consensus recommendation of "Hold" from the six brokerages that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average twelve-month price objective among anDecember 19 at 4:30 AM | marketbeat.comJPMorgan Chase & Co. Reaffirms "Neutral" Rating for Treace Medical Concepts (NASDAQ:TMCI)December 19 at 1:58 AM | americanbankingnews.comDeep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)December 18 at 4:42 PM | benzinga.comTruist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) StockTruist Financial increased their price objective on Treace Medical Concepts from $7.00 to $8.40 and gave the company a "hold" rating in a research report on Wednesday.December 18 at 10:45 AM | marketbeat.comTreace Medical assumed with a Neutral at JPMorganDecember 18 at 6:42 AM | markets.businessinsider.comTreace Medical Concepts' (TMCI) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.JPMorgan Chase & Co. reiterated a "neutral" rating and set a $8.00 price objective on shares of Treace Medical Concepts in a research report on Tuesday.December 17, 2024 | marketbeat.comTreace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ ImplantDecember 16, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmDecember 11, 2024 | prnewswire.comThe Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For FraudDecember 5, 2024 | stockhouse.comTreace announces cases using RedPoint Intelliguide PSI with AdductoplastyDecember 5, 2024 | markets.businessinsider.comTreace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot DeformitiesDecember 4, 2024 | globenewswire.comTreace Appoints Guy Guglielmino as Chief Commercial OfficerDecember 2, 2024 | globenewswire.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned an average recommendation of "Hold" from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating. The average 12-month prNovember 24, 2024 | marketbeat.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 22, 2024 | prnewswire.comTreace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law FirmNovember 21, 2024 | stockhouse.comTreace Announces Participation at Stifel 2024 Healthcare ConferenceNovember 18, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 12, 2024 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), MacroGenics (MGNX) and Novo Nordisk (NVO)November 7, 2024 | markets.businessinsider.comMorgan Stanley Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)November 7, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | insidermonkey.comTreace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 6, 2024 | finance.yahoo.comTreace Medical Concepts Reports Strong Q3 2024 GrowthNovember 6, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comTREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the FirmNovember 5, 2024 | globenewswire.comTreace Medical Concepts Reports Third Quarter 2024 Financial ResultsNovember 5, 2024 | globenewswire.comTreace Medical comments on CMS final rule for hospital outpatient, ASC settingsNovember 5, 2024 | markets.businessinsider.comTreace Medical announces limited release of Nanoplasty 3D MIS Bunion CorrectionNovember 5, 2024 | markets.businessinsider.comTreace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ ProcedureNovember 5, 2024 | markets.businessinsider.comEarnings Preview For Treace Medical ConceptsNovember 5, 2024 | benzinga.comTreace Announces Participation in the UBS Global Healthcare ConferenceNovember 4, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 4, 2024 | prnewswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsNovember 1, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsNovember 1, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsOctober 31, 2024 | businesswire.comTreace Medical participates in a conference call with BTIGOctober 31, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by AnalystsShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus recommendation of "Hold" by the six analysts that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-yearOctober 30, 2024 | marketbeat.comTreace Medical Concepts (TMCI) Scheduled to Post Quarterly Earnings on TuesdayTreace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Tuesday, November 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)October 29, 2024 | marketbeat.comTREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the FirmOctober 28, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 28, 2024 | prnewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 23, 2024 | prnewswire.comTreace to Report Third Quarter 2024 Financial Results on November 5, 2024October 22, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 22, 2024 | businesswire.comTreace Medical Concepts (NASDAQ:TMCI) PT Lowered to $6.00 at Truist FinancialTruist Financial reduced their price target on shares of Treace Medical Concepts from $7.50 to $6.00 and set a "hold" rating on the stock in a research report on Monday.October 14, 2024 | marketbeat.comTreace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion TechnologyOctober 14, 2024 | globenewswire.comMillennium Management LLC Trims Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Millennium Management LLC cut its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 66.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 686,012 shares of the company's stockOctober 13, 2024 | marketbeat.comTreace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...October 9, 2024 | finance.yahoo.comAlgert Global LLC Buys 104,236 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)Algert Global LLC raised its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 178.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 162,536 shares of the company's stock after acquiring an addOctober 5, 2024 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by AnalystsTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned an average rating of "Hold" from the six analysts that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation. The average 12-month priceOctober 5, 2024 | marketbeat.comMarshall Wace LLP Boosts Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Marshall Wace LLP boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 65.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 463,039 shares of the company's stock afteOctober 4, 2024 | marketbeat.com Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. TMCI Media Mentions By Week TMCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼0.250.60▲Average Medical News Sentiment TMCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼103▲TMCI Articles Average Week Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RxSight News InMode News MiMedx Group News Establishment Labs News BioLife Solutions News Pulse Biosciences News Artivion News Embecta News CeriBell News Liquidia News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMCI Stock Alerts